Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-24

Clinical Trial Update: Effects of Pectin Supplementation in Diarrhea-predominant Irritable Bowel Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pectin supplementation for diarrhea-predominant irritable bowel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pectin supplement (pectin)

Snippet

Sponsor: Nanjing PLA General Hospital | Conditions: Irritable Bowel Syndrome | Phase 3 | Status: COMPLETED